Cargando…

How the Immune System Responds to Allergy Immunotherapy

IgE-mediated diseases represent a highly diversified and multifactorial group of disorders that can deeply impact the patients’ quality of life. Currently, allergy immunotherapy (AIT) still remains the gold standard for the management of such pathologies. In this review, we comprehensively examine a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veneziani, Irene, Landolina, Nadine, Ricci, Biancamaria, Rossi, Oliviero, Moretta, Lorenzo, Maggi, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688006/ https://www.ncbi.nlm.nih.gov/pubmed/36359345 http://dx.doi.org/10.3390/biomedicines10112825

Ejemplares similares

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56(bright)CD16(−) subset
por: Veneziani, Irene, et al.
Publicado: (2022)

The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An Overview
por: Veneziani, Irene, et al.
Publicado: (2022)

IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells
por: Landolina, Nadine, et al.
Publicado: (2022)

Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal
por: Azzarone, Bruno, et al.
Publicado: (2021)

Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer?
por: Maggi, Enrico, et al.
Publicado: (2020)

Regulation of the Immune System Development by Glucocorticoids and Sex Hormones
por: Quatrini, Linda, et al.
Publicado: (2021)

How the immune system responds to therapeutic biological agents
por: Vultaggio, Alessandra, et al.
Publicado: (2016)

Analysis of the mechanisms regulating soluble PD-1 production and function in human NK cells
por: Mariotti, Francesca Romana, et al.
Publicado: (2023)

Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms’ Tumors
por: Pelosi, Andrea, et al.
Publicado: (2021)

COVID-19: Unanswered questions on immune response and pathogenesis
por: Maggi, Enrico, et al.
Publicado: (2020)

The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
por: Quatrini, Linda, et al.
Publicado: (2020)

What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders
por: Maggi, Enrico, et al.
Publicado: (2021)

Update on Allergy Immunotherapy
por: Davidson, William, et al.
Publicado: (2005)

Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
por: Pistoia, Vito, et al.
Publicado: (2018)

Aluminium in Allergies and Allergen immunotherapy
por: Jensen-Jarolim, Erika
Publicado: (2015)

Immunotherapy for cow's milk allergy
por: Taniuchi, Shoichiro, et al.
Publicado: (2017)

Egg Allergy: Diagnosis and Immunotherapy
por: Dona, Dulashi Withanage, et al.
Publicado: (2020)

The Potential of Exosomes in Allergy Immunotherapy
por: Engeroff, Paul, et al.
Publicado: (2022)

Oral and sublingual immunotherapy for food allergy
por: Le, Uyenphuong H, et al.
Publicado: (2014)

Immunotherapy of house dust mite allergy
por: Yang, Lin, et al.
Publicado: (2017)

Allergen-Specific Immunotherapies for Food Allergy
por: Feuille, Elizabeth, et al.
Publicado: (2018)

House dust allergy and immunotherapy
por: Thomas, Wayne R.
Publicado: (2012)

How to fit allergen immunotherapy in the elderly
por: Ridolo, Erminia, et al.
Publicado: (2017)

Egg Allergy in Children and Weaning Diet
por: Caffarelli, Carlo, et al.
Publicado: (2022)

Specific immunotherapy by the sublingual route for respiratory allergy
por: Incorvaia, Cristoforo, et al.
Publicado: (2010)

Peanut allergy: Beyond the oral immunotherapy plateau
por: Bruton, Kelly, et al.
Publicado: (2021)

Oral Immunotherapy for Children with Cow’s Milk Allergy
por: Ogata, Mika, et al.
Publicado: (2021)

Current Insights into Immunotherapy Approaches for Food Allergy
por: Macdougall, Jessica D, et al.
Publicado: (2021)

A practical view of immunotherapy for food allergy
por: Song, Tae Won
Publicado: (2016)

Improving the safety of oral immunotherapy for food allergy
por: Vazquez‐Ortiz, Marta, et al.
Publicado: (2015)

Allergen immunotherapy for food allergy: Evidence and outlook
por: Muraro, Antonella, et al.
Publicado: (2022)

Sublingual immunotherapy: World Allergy Organization position paper 2013 update
por: Canonica, Giorgio Walter, et al.
Publicado: (2014)

Peptide immunotherapy for childhood allergy - addressing translational challenges
por: Mackenzie, Karen J, et al.
Publicado: (2011)

Stinging insect allergy: current perspectives on venom immunotherapy
por: Ludman, Sian W, et al.
Publicado: (2015)

Preventive capacity of allergen immunotherapy on the natural history of allergy
por: INCORVAIA, C.
Publicado: (2013)

The Nuts and Bolts of Food Immunotherapy: The Future of Food Allergy
por: Anvari, Sara, et al.
Publicado: (2018)

Oral Immunotherapy in Food Allergy: Where Are We Now?
por: Özdemir, Pınar Gökmirza, et al.
Publicado: (2023)

Vespa crabro immunotherapy versus Vespula-venom immunotherapy in Vespa crabro allergy: a comparison study in field re-stings
por: Macchia, Donatella, et al.
Publicado: (2018)

New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ(®) tablets
por: Vitiello, Gianfranco, et al.
Publicado: (2020)

ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy
por: Bousquet, Jean, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dkaanr4bpgea77v4doa387hl9g